Reduced IGF-1 levels and/or impaired IGF-1 signal transduction may at least in part be responsible for enhanced muscle atrophy (sarcopenia), bone resorption (osteoporosis), and skin atrophy consistently observed in elderly individuals (Gallagher & LeRoith, 2011). The gene discussed is IGF1; the disease is sarcopenia.